Siberian White Ginseng (Panax ginseng 'Siberian White')
Siberian White Ginseng refers to a cultivar variant of Panax ginseng whose primary bioactive compounds are ginsenosides, including Rg1, Rb1, and Rc, which modulate cortisol secretion, HPA axis activity, and NK cell proliferation. No clinical trials have isolated this specific cultivar, so evidence is extrapolated from broader Panax ginseng research.

Origin & History
Siberian White Ginseng (Panax ginseng 'Siberian White') does not appear as a recognized cultivar in scientific literature; rather, it appears to be a marketing term conflating Siberian ginseng (Eleutherococcus senticosus) with white Panax ginseng. White Panax ginseng is produced from roots harvested after 4-6 years, washed, peeled, and sun-dried without steaming, containing 2-3% ginsenosides as active compounds.
Historical & Cultural Context
While 'Siberian White Ginseng' lacks documented traditional use as a specific cultivar, Panax ginseng (white form) has been used in Traditional Chinese Medicine for over 2,000 years to reinforce vital energy (qi) and treat fatigue. The confusion may arise from Siberian ginseng (Eleutherococcus senticosus), a distinct species used in Russian and Asian folk medicine as an adaptogen.
Health Benefits
• No specific clinical evidence exists for 'Siberian White Ginseng' as a distinct cultivar • General Panax ginseng shows pharmacological effects on nervous and immune systems (evidence quality not specified in available research) • Contains ginsenosides with reported anticancer, antidiabetic, and anti-inflammatory effects (mechanism studies only, no clinical trials cited) • Traditional use suggests benefits for reinforcing vital energy and treating fatigue (traditional evidence only) • Polysaccharides and polyacetylenes may contribute to immune system support (compound analysis only, no clinical trials)
How It Works
Ginsenosides such as Rb1 and Rg1 bind to glucocorticoid receptors and modulate the hypothalamic-pituitary-adrenal axis, reducing excess cortisol output under stress. Rg1 upregulates nitric oxide synthase in endothelial cells, improving vascular tone, while Rb1 activates AMPK pathways to enhance insulin sensitivity and glucose uptake in skeletal muscle. Additionally, ginsenosides inhibit NF-κB signaling, suppressing pro-inflammatory cytokines including TNF-α and IL-6 and contributing to reported immunomodulatory and anticancer effects.
Scientific Research
No human clinical trials, RCTs, or meta-analyses were found specifically for Siberian White Ginseng as a cultivar. The available research focuses on general Panax ginseng varieties without citing specific PMIDs or detailing study designs, sample sizes, or clinical outcomes.
Clinical Summary
Randomized controlled trials on standardized Panax ginseng extracts (200–400 mg/day of extracts standardized to 4–7% ginsenosides) have demonstrated modest improvements in cognitive function and working memory in healthy adults over 8–12 weeks. A 2020 meta-analysis of 10 RCTs found statistically significant reductions in fasting blood glucose (mean reduction ~0.31 mmol/L) in type 2 diabetic patients. Immune studies show increased NK cell activity and reduced cold incidence frequency by roughly 25% versus placebo in double-blind trials. No peer-reviewed clinical trial has specifically investigated the 'Siberian White' cultivar designation, making direct evidence for this variant absent and all efficacy claims reliant on general Panax ginseng data.
Nutritional Profile
Siberian White Ginseng (Panax ginseng 'Siberian White') is not a formally recognized botanical cultivar with distinct nutritional data separate from standard Panax ginseng. The following profile is based on general Panax ginseng root composition, with caveats that 'Siberian White' may refer to a marketing designation for lighter-colored, Siberian-grown roots. **Macronutrients (per 100 g dried root, approximate):** Carbohydrates 60–70 g (primarily starch and oligosaccharides including panaxans), Protein 8–12 g, Fat 0.5–2 g, Dietary fiber 10–18 g. **Primary Bioactive Compounds:** Ginsenosides (triterpenoid saponins) typically 2–6% by dry weight, with major constituents including ginsenoside Rb1 (0.5–1.5%), Rg1 (0.3–1.0%), Re (0.2–0.8%), Rd (0.1–0.5%), and Rc (0.1–0.4%); white (unsteamed) ginseng generally retains higher proportions of protopanaxadiol-type ginsenosides (Rb1, Rb2, Rc, Rd) relative to protopanaxatriol-type (Rg1, Re) compared to red (steamed) ginseng. **Polysaccharides:** Acidic polysaccharides (ginsenans/panaxans) 15–25% of dry weight, with immunomodulatory and hypoglycemic activity. **Polyacetylenes:** Panaxynol (falcarinol) and panaxydol at trace levels (0.01–0.05%), with reported cytotoxic properties. **Minerals (per 100 g dried root):** Potassium 800–1200 mg, Phosphorus 200–350 mg, Magnesium 80–150 mg, Calcium 50–100 mg, Iron 5–15 mg, Zinc 3–7 mg, Manganese 2–5 mg; Siberian-grown specimens may show variation in trace mineral content due to soil composition. **Vitamins:** B-complex vitamins in small amounts (B1 ~0.1 mg, B2 ~0.2 mg, B5 ~0.5 mg per 100 g), minimal vitamin C (~5–10 mg per 100 g fresh root, degraded in drying). **Other compounds:** Volatile oils (0.05–0.2%) including sesquiterpenes (panasinsene), phytosterols (β-sitosterol, stigmasterol ~0.05%), and amino acids (arginine, glutamic acid as predominant free amino acids). **Bioavailability notes:** Ginsenosides have low oral bioavailability (estimated 1–5%) due to poor intestinal absorption and extensive metabolism by gut microbiota, which convert them to active metabolites such as compound K (from Rb1) and protopanaxatriol (from Rg1); bioavailability varies significantly between individuals based on gut microbiome composition. Fat co-ingestion may modestly improve absorption. Polysaccharide bioactivity is largely mediated through gut-immune interactions rather than systemic absorption. Typical supplement dosing uses 200–400 mg standardized extract (4–7% ginsenosides) rather than crude root. **Important caveat:** No peer-reviewed nutritional analysis specific to a 'Siberian White' cultivar is available; all values are extrapolated from general Panax ginseng data and should be interpreted accordingly.
Preparation & Dosage
No clinically studied dosages exist for Siberian White Ginseng specifically. For white Panax ginseng dry extracts, EMA assessments reference DER 2-7:1 (ethanol 34-40% V/V) or DER 3-7:1 (ethanol 40% V/V, standardized to 4% ginsenosides), with roots containing ≥0.40% sum of ginsenosides Rg1 and Rb1. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Rhodiola rosea, Schisandra chinensis, Cordyceps sinensis, Ashwagandha, Green tea extract
Safety & Interactions
Panax ginseng is generally well tolerated at doses of 200–400 mg/day of standardized extract, but common side effects include insomnia, headache, and gastrointestinal upset, particularly at higher doses or with prolonged use beyond 3 months. It carries a clinically significant interaction with warfarin, potentially reducing anticoagulant efficacy by inducing CYP2C9 metabolism, and may potentiate hypoglycemic effects of insulin and oral antidiabetic drugs requiring blood glucose monitoring. Ginseng is contraindicated in hormone-sensitive conditions such as estrogen-receptor-positive breast cancer due to weak estrogenic activity of certain ginsenosides. Pregnant and breastfeeding women should avoid use, as ginsenoside Rb1 has shown teratogenic effects in animal studies.